404 related articles for article (PubMed ID: 11843286)
1. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.
Fujimura Y; Matsumoto M; Yagi H; Yoshioka A; Matsui T; Titani K
Int J Hematol; 2002 Jan; 75(1):25-34. PubMed ID: 11843286
[TBL] [Abstract][Full Text] [Related]
2. Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome.
Sasahara Y; Kumaki S; Ohashi Y; Minegishi M; Kano H; Bessho F; Tsuchiya S
Int J Hematol; 2001 Jul; 74(1):109-14. PubMed ID: 11530799
[TBL] [Abstract][Full Text] [Related]
3. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.
Kinoshita S; Yoshioka A; Park YD; Ishizashi H; Konno M; Funato M; Matsui T; Titani K; Yagi H; Matsumoto M; Fujimura Y
Int J Hematol; 2001 Jul; 74(1):101-8. PubMed ID: 11530798
[TBL] [Abstract][Full Text] [Related]
4. Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress.
Yagi H; Konno M; Kinoshita S; Matsumoto M; Ishizashi H; Matsui T; Titani K; Fujimura Y
Br J Haematol; 2001 Dec; 115(4):991-7. PubMed ID: 11843838
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
6. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
7. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
Soejima K; Nakagaki T
Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
[TBL] [Abstract][Full Text] [Related]
8. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
10. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura.
Zheng X; Chung D; Takayama TK; Majerus EM; Sadler JE; Fujikawa K
J Biol Chem; 2001 Nov; 276(44):41059-63. PubMed ID: 11557746
[TBL] [Abstract][Full Text] [Related]
11. Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation.
Park YD; Yoshioka A; Kawa K; Ishizashi H; Yagi H; Yamamoto Y; Matsumoto M; Fujimura Y
Bone Marrow Transplant; 2002 May; 29(9):789-94. PubMed ID: 12040478
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
15. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
16. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
[TBL] [Abstract][Full Text] [Related]
17. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
te Loo DM; Levtchenko E; Furlan M; Roosendaal GP; van den Heuvel LP
Pediatr Nephrol; 2000 Aug; 14(8-9):762-5. PubMed ID: 10955922
[TBL] [Abstract][Full Text] [Related]
18. [TTP/HUS and VWF/ADAMTS-13].
Fujimura Y
Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
[No Abstract] [Full Text] [Related]
19. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
20. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
